EFFECT OF HEPARIN INFECTION ON PLASMA PROTEIN BINDING OF BILIRUBIN AND SALICYLATE IN RATSWIEGAND UW; LEVY G.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 12; PP. 1483-1486; BIBL. 22 REF.Article

ISOSORBIDE DINITRATE KINETICS AND DYNAMICS AFTER INTRAVENOUS, SUBLINGUAL, AND PERCUTANEOUS DOSING IN ANGINAMORRISON RA; WIEGAND UW; JAEHNCHEN E et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 19; NO 6; PP. 747-756; BIBL. 35 REF.Article

INTERACTIONS OF SOME PARASYMPATHOLYTICS AND STRUCTURALLY RELATED DRUGS WITH ACETYCHOLINESTERASES: KINETIC STUDIES.WIEGAND UW; KUHNEN H; HALLER R et al.1976; BIOCHEM. PHARMACOL.; G.B.; DA. 1976; VOL. 25; NO 15; PP. 1719-1726; BIBL. 25 REF.Article

UNTERSUCHUNGEN ZUR BINDUNG EINIGER PARASYMPATHOLYTIKA AN RINDERSERUMALBUMIN: MESSUNGEN DER RELAXATIONSZEITEN = RECHERCHES SUR LA FIXATION DE CERTAINS PARASYMPATHOLYTIQUES SUR L'ALBUMINE DU SERUM: MESURE DES TEMPS DE RELAXATIONWIEGAND UW; WEDER HG; HALLER R et al.1975; ARZNEIMITTEL FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 7; PP. 1008-1013; ABS. ANGL.; BIBL. 17REF.Article

WECHSELWIRKUNGEN EINIGER PARASYMPATHOLYTIKA UND STRUKTURELL AEHNLICHER ARZNEIMITTEL MIT RINDERSERUMALBUMIN = INTERACTIONS DE QUELQUES PARASYMPATHOLYTIQUES ET DE MEDICAMENTS DE STRUCTURE SEMBLABLES AVEC L'ALBUMINE DU SERUM DU BOEUFWIEGAND UW; WEDER HG; HALLER R et al.1975; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1975; VOL. 25; NO 6; PP. 839-843; BIBL. 28REF.Article

EFFECT OF HEPARIN ON BILIRUBIN CLEARANCE IN RATS: PHARMACOKINETIC CONSEQUENCES OF EXTENSIVE HEPATIC EXTRACTION OF PLASMA PROTEIN BINDING INHIBITORSWIEGAND UW; SODA DM; LEVY G et al.1980; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1980; VOL. 69; NO 10; PP. 1228-1230; BIBL. 25 REF.Article

CHANGES IN PLASMA PROTEIN BINDING OF DRUGS AFTER BLOOD COLLECTION FROM PREGNANT WOMENCHOU RC; WIEGAND UW; LELE AS et al.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 716-718; BIBL. 8 REF.Article

PROTEIN BINDING OF SEVERAL DRUGS IN SERUM AND PLASMA OF HEALTHY SUBJECTSWIEGAND UW; HINTZE KL; SLATTERY JT et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 3; PP. 297-300; BIBL. 19 REF.Article

BINDUNGSMODELLE UND IHRE ANWENDUNG IN DER LEBENSMITTELCHEMIE = MODELES DE LIAISON ET LEUR EMPLOI EN CHIMIE ALIMENTAIREBEYELER M; SOLMS J; WIEGAND UW et al.1974; SCI.+TECHNOL. ALIMENT.; SUISSE; DA. 1974; VOL. 7; NO 6; PP. 313-317; ABS. ANGL.; BIBL. 20 REF.Article

PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF ALINIDINE IN MANWIEGAND UW; KASPER W; MEINERTZ T et al.1982; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1982; VOL. 4; NO 1; PP. 59-62; BIBL. 15 REF.Article

DISPOSITION OF AZAPROPAZONE IN CHRONIC RENAL AND HEPATIC FAILUREBREVING KH; GILFRICH HJ; MEINERTZ T et al.1981; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1981; VOL. 20; NO 2; PP. 147-155; BIBL. 25 REF.Article

DIFFERENCES IN THE PROTEIN BINDING OF SEVERAL DRUGS AND BILIRUBIN IN SERUM AND HEPARINIZED PLASMA OF RATSWIEGAND UW; SLATTERY JT; HINTZE KL et al.1979; LIFE SCI.; GBR; DA. 1979; VOL. 25; NO 5; PP. 471-478; BIBL. 22 REF.Article